CapsoVision Q3 Loss Widens as Operating Costs Rise, R&D Spending Increases

CapsoVision reported a Q3 net loss of $7.9 million, up from $5.8 million last year, with operating costs increasing to $9.93 million from $7.46 million. Net revenue rose to $3.54 million, up from $2.97 million, and gross profit increased to $1.91 million from $1.66 million. The company highlighted continued investment in research and development, with total R&D spending rising to $6.1 million from $4.5 million last year.